Locations:
Search IconSearch

Cancer

Person hugging in support group
February 25, 2026/Cancer/Patient Support

Treating Substance Use Disorder in Patients with Cancer

Bringing empathy and evidence-based practice to addiction medicine

Drs. Turk and Khatri headshots
February 23, 2026/Cancer/Podcast

Beyond Mammography (Podcast)

Supplemental screening for dense breasts

Dr. Elvin Zan headshot
February 17, 2026/Cancer/Podcast

Expanding Cancer Treatment with Theranostics (Podcast)

Combining advanced imaging with targeted therapy in prostate cancer and neuroendocrine tumors

melanoma
February 13, 2026/Digestive/Case Study

Case Study: An Immunotherapy-First Approach for a 79-Year-Old With Stage IIB Melanoma

Benefits of neoadjuvant immunotherapy reflect emerging standard of care

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Man touching lymph nodes
February 12, 2026/Cancer

EGFR-MET Bispecific Antibody Shows Promise for Metastatic Head & Neck Cancer

Early results show strong clinical benefit rates

brain scan showing a large white-rimmed lesion in top left portion
February 11, 2026/Neurosciences/Brain Tumor

Novel Strategies to Enhance Chemotherapy in Advanced Glioblastoma

Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies

Bispecific antibodies
February 10, 2026/Cancer/Blood Cancers

MajesTEC-3 Trial Outcomes May Change Course of Myeloma Treatment

The shifting role of cell therapy and steroids in the relapsed/refractory setting

Hands after RT
January 30, 2026/Cancer/Radiation Oncology

Patient Case Study: Radiation Therapy Used to Treat Dupuytren's Disease

Radiation therapy helped shrink hand nodules and improve functionality

Dr. Ali and patient
January 29, 2026/Cancer/News & Insight

Real-World Data Reveals Gap Between Guidelines and Practice in HER2+ Breast Cancer Care

Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches

Dr. Silver in lab

HPV-Negative Tumors Harbor More Oncobacteria, Study Finds

Analysis of HNSCC patients shows HPV status to be predictive of higher abundance of oncobacteria within the tumor

BackPage 1 of 87Next

Advertisement

Ad